Focus
View

Alnylam Pharmaceuticals, Inc.

ALNY

MIXED

CEO Package

—

Pay Ratio

—

Alnylam Pharmaceuticals, Inc.

Awaiting a fuller pay-performance history

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

J. Duato

Returns outran pay growth by +16.0 pts

ELI LILLY & Co

LLY · FY2025

ALIGNED

CEO Package

$30.2M

Pay Ratio

—

David A. Ricks

Returns outran pay growth by +3.5 pts

CEO Total Compensation — All Companies

ALNYJNJ$32.8MLLY$30.2M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

ALNY reads mixed, while JNJ looks aligned.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

ALNY

Alnylam Pharmaceuticals, Inc.

—

Component-level breakdown is unavailable for this company.

JNJ

J. Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

LLY

David A. Ricks

$30.2M

base salary6%
stock awards77%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
Alnylam Pharmaceuticals, Inc.(ALNY)N/A2025N/A
JOHNSON & JOHNSON(JNJ)J. Duato2025$32.8M
ELI LILLY & Co(LLY)David A. Ricks2025$30.2M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.